Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-Associated uveitis

  1. Quesada-Masachs, E.
  2. Caballero, C.M.
Revue:
Journal of Rheumatology

ISSN: 1499-2752,  0315-162X

Année de publication: 2017

Volumen: 44

Número: 2

Pages: 260-261

Type: Lettre

DOI: 10.3899/JRHEUM.160908 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus